Here are five things to know:
1. On Dec. 2, 2016, Envision shares had a 52-week high of $71.05.
2. Analysts have a price target of $29.50 on Envision shares.
3. The companies’ shareholders approved the deal at separate meetings on Dec. 1, 2016.
4. Holders of more than 82 percent of Envision shares approved the merger.
5. Holders of 88 percent of AmSurg shares gave the green light for the deal.
More articles on surgery centers:
10 new outpatient surgery centers in November 2016
10 new outpatient surgery centers in November 2016
AmSurg, Envision Healthcare shareholders approve merger — 4 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.